The Preimplantation Genetic Testing Market is segmented by application, with Diagnostic Testing holding the largest share, while Carrier Screening is identified as the fastest-growing segment. These two applications address different but complementary needs in reproductive medicine, together forming the core of the market.

Diagnostic Testing, often referred to as PGT for aneuploidy (PGT-A) and PGT for monogenic disorders (PGT-M), is the dominant application. PGT-A is used to screen embryos for chromosomal abnormalities, such as having an extra or missing chromosome (aneuploidy). These abnormalities are a primary cause of implantation failure, miscarriage, and conditions like Down syndrome. PGT-A is particularly valuable for women of advanced maternal age, who have a higher risk of producing aneuploid embryos. PGT-M, on the other hand, is used for couples who are known carriers of specific inherited genetic disorders, such as cystic fibrosis, Huntington's disease, or sickle cell anemia. It allows them to select embryos that are not affected by the disease, preventing its transmission to their children. The critical role of these tests in improving IVF success rates and preventing hereditary diseases solidifies Diagnostic Testing's leading market position.

The rapid growth of the Carrier Screening segment reflects a shift towards more proactive and preventative reproductive healthcare. Carrier screening is performed on prospective parents before they begin IVF, to determine if they carry a recessive gene for a genetic disorder. If both parents are carriers, there is a 25% chance their child could be affected by the condition. By identifying these risks upfront, couples can make informed decisions about their family-building options, including the use of PGT-M during IVF to select unaffected embryos. The appeal of carrier screening lies in its proactive nature. As awareness grows and the cost of genetic testing falls, more individuals and couples are opting for this screening as part of their pre-conception planning. This trend is driving significant growth in this segment, making it a key area of focus for market players and a vital tool in the quest for healthy pregnancies.